Yayın ve Makaleleri

YavuzSalihoglu

Prof.Dr. M.Yavuz SALİHOĞLU

1959 yılında Antalya’da doğdu.

İlk, orta ve lise öğrenimini TED Ankara Koleji’nde tamamladı.

1982 yılında Ankara Tıp Fakültesi’ni bitirdi.

1983-1985 yılları arasında mecburi hizmetini tamamlayarak İstanbul Tıp Fakültesi Kadın Hastalıkları ve Doğum Kiliniği’nde asistanlığa başladı.

1989 yılında kadın hastalıkları ve doğum uzmanı oldu ve aynı yıl ABD Vanderbil Üniversitesi Hastanesi’nde Jinekolojik Onkoloji Bölümü’nde ‘research fellow’ olarak çalışmaya başladı.

Bir yıl süren bu dönem sonunda 1990 yılında Türkiye’ye dönerek İstanbul Tıp Fakültesi Kadın Hastalıkları ve Doğum Anabilim Dalı’na başasistan olarak girdi.

1995 yılında doçent ve 2000 yılında profesör oldu.

Halen aynı kurumda öğretim üyesi olarak görev yapıyor.


 

YAYINLAR VE MAKALELER

Tertiary Cytoreduction for Recurrent Epithelial Ovarian Cancer: a Multicenter Study in Turkey

Arvas M, Salihoglu Y, Sal V, Gungor T, Sozen H, Kahramanoglu I, Topuz S, Demirkiran F, Iyibozkurt C, Bese T, Ozgu BS, Vatansever D, Tokgozoglu N, Berkman S, Turan H, Bengisu E, Sofiyeva N, Demiral I, Meydanli M.  Asian Pac J Cancer Prev. 2016;17(4):1909-15.

Surgical Treatment of Metastatic Ovarian Tumors From Extragenital Primary Sites.

Sal V1, Demirkiran F, Topuz S, Kahramanoglu I, Yalcin I, Bese T, Sozen H, Tokgozoglu N, Salihoglu Y, Turan H, Iyibozkurt C, Kolomuc T, Sofiyeva N, Berkman S, Arvas M.

Int J Gynecol Cancer. 2016 May;26(4):688-96. doi: 10.1097/IGC.0000000000000673.

Combination of adjuvant chemotherapy and radiotherapy is associated with improved survival at early stage type II endometrial cancer and carcinosarcoma.

Sozen H1, Çiftçi R2, Vatansever D1, Topuz S1, Iyibozkurt AC1, Bozbey HU2, Yaşa C1, Çali H1, Yavuz E3, Kucucuk S4, Aydiner A2, Salihoglu Y1.

Aust N Z J Obstet Gynaecol. 2016 Apr;56(2):199-206. doi: 10.1111/ajo.12449. Epub 2016 Feb 18.

Clinicopathologic and survival analyses of synchronous primary endometrial and epithelial ovarian cancers.

Sozen H1, Vatansever D1, Iyibozkurt AC1, Topuz S1, Ozsurmeli M1, Salihoglu Y1, Guzelbey B2, Berkman S1.

J Obstet Gynaecol Res. 2015 Nov;41(11):1813-9. doi: 10.1111/jog.12826. Epub 2015 Sep 14.

Factors affecting recurrence and disease-free survival in granulosa cell tumors of the ovary.

Iyibozkurt AC1, Topuz S, Gungor F, Akhan SE, Demirci F, Salihoglu Y, Berkman S, Bengisu E

Eur J Gynaecol Oncol. 2010;31(6):667-71.

Do obesity and age effect the clinicopathological features and survival outcomes in premenopausal women with endometrial cancer?

Topuz S, Sozen H, Vatansever D, İyibozkurt A.C,  Oygur B, Bastu E, Salihoglu Y, Berkman S

Eur J Gynaecol Oncol. 2016 2662-34

Factors affecting recurrence and disease-free survival in granulosa cell tumors of the ovary.

Iyibozkurt AC, Topuz S, Gungor F, Akhan SE, Demirci F, Salihoglu Y, Berkman S, Bengisu E.

Eur J Gynaecol Oncol. 2010;31(6):667-71.

Life-saving hysterectomy in choriocarcinoma: presentation of two cases.
Topuz S, Iyibozkurt C, Mete O, Akhan S, Salihoğlu Y, Bengisu E, Berkman S.

Eur J Gynaecol Oncol. 2008;29(6):664-5.

Malignant germ cell tumors of the ovary: a review of 41 cases and risk factors for recurrence.
Topuz S, Iyibozkurt AC, Akhan SE, Keskin N, Yavuz E, Salihoglu Y, Bengisu E, Berkman S.

Eur J Gynaecol Oncol. 2008;29(6):635-7.

Mucinous adenocarcinoma arising in ovarian mature cystic teratoma in pregnancy.
Ulker V, Gedikbasi A, Numanoglu C, Ozluk Y, Saygi S, Gulkilik A, Salihoglu Y.

Arch Gynecol Obstet. 2009 Aug;280(2):287-91. doi: 10.1007/s00404-008-0878-y. Epub 2008 Dec 20.

Invasive squamous carcinoma of the vulva in women aged less than 40 years: report of two cases and a third case diagnosed during pregnancy.
Keskin N, Iyibozkurt AC, Topuz S, Salihoğlu Y, Bengisu E, Berkman S.

Eur J Gynaecol Oncol. 2008;29(4):399-401.

Analysis of vaginal recurrences in stage I endometrial adenocarcinoma.
Salihoğlu Y, Keskin N, Topuz S, Küçücük S, Iyibozkurt C.

Eur J Gynaecol Oncol. 2007;28(4):313-5.

Brain metastasis of ovarian cancer after negative second-look laparotomy.
Akhan SE, Işikoglu M, Salihoglu Y, Bengisu E, Berkman S.

Eur J Gynaecol Oncol. 2002;23(4):330-2.

Prognostic role of nm23 gene expression in patients with ovarian cancer.
Tas F, Tuzlali S, Aydiner A, Saip P, Salihoglu Y, Iplikci A, Topuz E.

Am J Clin Oncol. 2002 Apr;25(2):164-7.

The role of chemotherapy in malignant mixed mullerian tumors of the female genital tract.
Topuz E, Eralp Y, Aydiner A, Saip P, Taş F, Yavuz E, Salihoğlu Y.
Eur J Gynaecol Oncol. 2001;22(6):469-72.

Nongenital metastatic cancers of the ovary: a clinical analysis.
Akhan SE, Kilic G, Salihoglu Y, Bengisu E, Berkman S.

Eur J Gynaecol Oncol. 2001;22(5):379-83.

Thymidine labeling index in epithelial ovarian cancer.
Salihoglu Y, Bilir A, Aydiner A, Erkan M, Tuzlali S, Eralp Y.

Int J Gynaecol Obstet. 2001 Nov;75(2):171-6.

The efficacy of combination chemotherapy including intraperitoneal cisplatinum and mitoxantrone with intravenous ifosfamide in patients with FIGO stage I C ovarian carcinoma.

Topuz E, Eralp Y, Saip P, Aydiner A, Taş F, Saliho Y, Salihoğlu Y, Berkman S, Bengisu E.

Eur J Gynaecol Oncol. 2001;22(1):70-3.

Correlations of serum CA125 level and computerized tomography (CT) imaging with laparotomic findings following intraperitoneal chemotherapy in patients with ovarian cancer.

Topuz E, Aydiner A, Saip P, Eralp Y, Taş F, Salihoğlu Y, Tenekeci N.

Eur J Gynaecol Oncol. 2000;21(6):599-602.

Celsite port and catheter as an intraperitoneal access device in the treatment of ovarian cancer.
Topuz E, Salihoglu Y, Aydiner A, Saip P, Tas F, Sozen T, Berkman S, Bengisu E.

J Surg Oncol. 2000 Jul;74(3):223-6.

Catheter complications associated with intraperitoneal chemotherapy.
Topuz E, Saip P, Aydiner A, Salihoglu Y, Aydin Y, Topuzlu C.

Eur J Gynaecol Oncol. 1998;19(3):275-9. Erratum in: Eur J Gynaecol Oncol 1998;18(5):430.

Intraperitoneal cisplatin-mitoxantrone and intravenous ifosfamide combination as first-line treatment of ovarian cancer.
Topuz E, Saip P, Aydmer A, Salihoğlu Y, Berkman S, Bengisu E.

Eur J Gynaecol Oncol. 1998;19(3):265-70.